Cite
APA Citation
Vertechy, L., Boccia, S. M., Tiberi, G., Avesani, G., Corrado, G., Fagotti, A., Scambia, G., & Marchetti, C. (2023). trabectedin plus pegylated liposomal doxorubicin in patients with disease progression after PARP inhibitor maintenance: a real-life case–control study. International journal of gynecological cancer, 33(2), 243–249. http://access.bl.uk/ark:/81055/vdc_100179392086.0x00004e